First Time Loading...

Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 40.15 HKD 0.25% Market Closed
Updated: May 20, 2024

EV/EBITDA
Enterprise Value to EBITDA

-40.3
Current
-28
Median
4.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-40.3
=
Enterprise Value
47.4B
/
EBITDA
-1.1B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-62.8
2-Years Forward
EV/EBITDA
65.3
3-Years Forward
EV/EBITDA
21.7

See Also

Discover More